PUK15 COST-EFFECTIVENESS ANALYSIS OF THREE MONTHS TREATMENT WITH FESOTERODINE COMPARED TO GENERIC OXYBUTYNIN EXTENDED-RELEASE IN WOMEN WITH URINARY INCONTINENCE FROM A THIRD PARTY PAYER PERSPECTIVE
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72370-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)72370-6/fulltext
Section Title :
Section Order :
970
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72370-6&doi=10.1016/S1098-3015(10)72370-6